COVAX says India's Serum Institute bound to supply virus vaccines
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SUNDAY, MAY 29, 2022
SUNDAY, MAY 29, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
COVAX says India's Serum Institute bound to supply virus vaccines

Coronavirus chronicle

Reuters
09 April, 2021, 01:00 pm
Last modified: 09 April, 2021, 01:04 pm

Related News

  • Indian vaccine giant Serum plans African plant in global expansion
  • France donates 2.12 million more AstraZeneca shots to Bangladesh
  • Health minister to receive 55lakh Covid vaccines donated by UK, Japan
  • Omicron-specific booster shot possible: SII CEO Adar Poonawalla
  • Serum Institute to resume supply of Covishield to Covax: Reports

COVAX says India's Serum Institute bound to supply virus vaccines

"The agreement is legally binding and served as a basis for the first-round allocation document, which has been communicated to all participating economies," a Gavi spokeswoman said

Reuters
09 April, 2021, 01:00 pm
Last modified: 09 April, 2021, 01:04 pm
FILE PHOTO: A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which is developing a vaccine against the coronavirus disease (Covid-19) at its laboratory in Pune, India, May 18, 2020. REUTERS/Euan Rocha
FILE PHOTO: A man walks past a signpost of India's Serum Institute, the world's largest maker of vaccines, which is developing a vaccine against the coronavirus disease (Covid-19) at its laboratory in Pune, India, May 18, 2020. REUTERS/Euan Rocha

The Serum Institute of India (SII) is legally compelled to ship coronavirus vaccine to global vaccine sharing facility COVAX, its co-lead Gavi has told Reuters, a provision that could complicate the firm's efforts to boost domestic supplies.

India, where infections have surged to 13.06 million, suspended all major exports of vaccines last month to fill demand at home, forcing the world's biggest vaccine maker to divert nearly all its production to the domestic market.

"The agreement is legally binding and served as a basis for the first-round allocation document, which has been communicated to all participating economies," a Gavi spokeswoman said in an email.

The pact specified Gavi would receive from SII 1.1 billion doses of either the AstraZeneca vaccine or that of Novavax , with 200 million committed, and the rest on option.

SII partner AstraZeneca has already issued it a legal notice over delays to other shipments, even as many Indian states have complained of a shortage facing priority recipients. .

Gavi said its pact with SII took effect when the World Health Organization approved the AstraZeneca shot on Feb. 15, after a source said SII had originally been supposed to send doses to COVAX only from May.

"SII has pledged that, alongside supplying India, it will prioritise the COVAX multilateral solution for equitable distribution," Gavi added.

COVAX had expected https://www.gavi.org/sites/default/files/covid/covax/COVAX-First-round-a... a total of more than 100 million doses from SII between February and May, excluding supplies for India, but has so far received https://www.mea.gov.in/vaccine-supply.htm only about 18.2 million.

Serum has sent another 10 million doses to the Indian government through COVAX, Gavi said.

Gavi did not respond on Friday to questions about what now lies ahead. SII also did not immediately respond to a request for comment.

From an initial August target of vaccine coverage for 300 million of its highest-risk people, or just over a fifth of its population of 1.35 billion, India has upped the figure by about 100 million, adding pressure on SII to crank up supplies.

India could resume vaccine exports by June, the firm's chief executive, Adar Poonawalla, told media this week.

The firm has also sought $403 million from New Delhi as a grant to boost monthly output to more than 100 million doses by end-May, from 65 million to 70 million now.

On Thursday, the foreign ministry said domestic demand would determine the extent of India's exports. It has already shipped 64.5 million doses and given out 92 million at home.

Top News

COVAX Vaccine Facility / Serum Institute of India (SII)

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Central bankers’ refusal to embark into ‘hard helicopter money’ experiment have been a good idea. Photo: Reuters
    Interbank exchange rate for dollar set at Tk89
  • A Regio regional passenger train operated by Deutsche Bahn AG travels on a bridge in Berlin. Photographer: Krisztian Bocsi/Bloomberg
    Why Germany is offering a summer of cheap trains
  • Patients opting to delay crucial treatment amid rising costs
    Patients opting to delay crucial treatment amid rising costs

MOST VIEWED

  • A woman wearing a face mask crosses a road at the Central Business District (CBD), amid the coronavirus disease (Covid-19) outbreak in Beijing, China May 10, 2022. REUTERS/Carlos Garcia Rawlins
    Shanghai to lift 'unreasonable' curbs on firms, Beijing eases restrictions
  • Photo: Collected
    US doctors reconsider Pfizer's Paxlovid for lower-risk Covid patients
  • People wearing protective face masks walk on a street, following new cases of the coronavirus disease (Covid-19), in Shanghai, China August 25, 2021. REUTERS/Aly Song
    'Tomorrow will be better': Shanghai inches towards Covid re-opening
  • North Korea says new fever cases under 100,000 as virus fight heats up
    North Korea says new fever cases under 100,000 as virus fight heats up
  • People in protective suits cross a street during lockdown, amid the coronavirus disease (COVID-19) pandemic, in Shanghai, China, May 26, 2022. REUTERS/Aly Song
    Shanghai heading out of lockdown but China still lost in economic gloom
  • A woman wearing a face mask crosses a road at the Central Business District (CBD), amid the coronavirus disease (Covid-19) outbreak in Beijing, China May 10, 2022. REUTERS/Carlos Garcia Rawlins
    Tightening Covid net, Beijing deals out punishments, stark warnings

Related News

  • Indian vaccine giant Serum plans African plant in global expansion
  • France donates 2.12 million more AstraZeneca shots to Bangladesh
  • Health minister to receive 55lakh Covid vaccines donated by UK, Japan
  • Omicron-specific booster shot possible: SII CEO Adar Poonawalla
  • Serum Institute to resume supply of Covishield to Covax: Reports

Features

Central bankers’ refusal to embark into ‘hard helicopter money’ experiment have been a good idea. Photo: Reuters

Venice has a 400-year-old Covid monetary lesson

2h | Panorama
Aiman R Khan. Illustration: TBS

Why ‘marry your rapist’ court orders are not always what they seem

5h | Thoughts
Photo: Collected

Top 3 The Ordinary products that give extraordinary results

7h | Mode
Photo: Courtesy

KVN Beauty: Channel your inner Bangalee baddie

7h | Mode

More Videos from TBS

Paper industry worth thousands of crores in Bogura

Paper industry worth thousands of crores in Bogura

2h | Videos
Photo: TBS

Tips to help you become a successful lawyer

8h | Videos
Photo: TBS

Harassment over 'indecent clothing': Women gather at Narsingdi railway station to protest, show solidarity

8h | Videos
People bid adieu to Abdul Gaffar Chowdhury

People bid adieu to Abdul Gaffar Chowdhury

8h | Videos

Most Read

1
Bangladesh Bank GM, DGM’s designation changed
Banking

Bangladesh Bank GM, DGM’s designation changed

2
Corporates go cashless…tax cut on cards
NBR

Corporates go cashless…tax cut on cards

3
Photo: Courtesy
Panorama

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

4
British International Investment (BII) CEO Nick O’Donohoe. Illustration: TBS
Economy

BII to invest $450m in Bangladesh in 5 years

5
Representational image. Picture: Pixabay
Economy

Govt raises regulatory duty to discourage imports of 130 products

6
Photo: Collected
Industry

Spanish recycled cotton producer opens new facility in Bangladesh

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab